- Home
- PYPL vs BDX Comparison
PYPL vs BDX Comparison
Compare PYPL & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PYPL | BDX |
|---|---|---|
| Founded | 1998 | 1897 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.3B | 43.0B |
| IPO Year | 2015 | 1997 |
Fundamental Metrics
Financial Performance| Metric | PYPL | BDX |
|---|---|---|
| Price | $46.21 | $151.98 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 30 | 13 |
| Target Price | $61.48 | ★ $186.00 |
| AVG Volume (30 Days) | ★ 13.8M | 2.4M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | 1.10% | ★ 2.89% |
| EPS Growth | ★ 35.59 | N/A |
| EPS | ★ 1.21 | 0.25 |
| Revenue | ★ $33,172,000,000.00 | $21,840,000,000.00 |
| Revenue This Year | $4.78 | N/A |
| Revenue Next Year | $4.24 | $3.02 |
| P/E Ratio | ★ $37.43 | $602.76 |
| Revenue Growth | 4.32 | ★ 8.24 |
| 52 Week Low | $38.46 | $140.11 |
| 52 Week High | $79.50 | $213.08 |
Technical Indicators
Market Signals| Indicator | PYPL | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 60.41 | 52.74 |
| Support Level | $43.13 | $141.69 |
| Resistance Level | $48.21 | $153.09 |
| Average True Range (ATR) | 1.28 | 4.09 |
| MACD | 0.41 | 0.19 |
| Stochastic Oscillator | 95.93 | 62.46 |
Price Performance
Historical ComparisonAbout PYPL PayPal Holdings Inc.
PayPal was spun off from eBay in 2015 and provides electronic payment solutions to merchants and consumers, with a focus on online transactions. The company had 439 million active accounts at the end of 2025. The company also owns Venmo, a person-to-person payment platform.
About BDX Becton Dickinson and Company
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.